Journal of Clinical Endocrinology & Metabolism, Vol 64, 425-432, Copyright © 1987 by Endocrine Society

ARTICLES

Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists

KA Eidne, CA Flanagan, NS Harris and RP Millar

GnRH-binding sites have previously been described in human breast tumors, and a GnRH agonist has been shown to inhibit growth of the MCF- 7 human breast cancer cell line. We have investigated the presence of GnRH-binding sites in ZR-75-1, MDA-MB-231, Sk Br 3, MDA-MB-157, and MCF- 7 human breast cancer cell lines and the effect of GnRH analogs on the incorporation of [3H]thymidine and 14C-labeled amino acids into DNA and protein. Specific GnRH-binding sites were present in membrane preparations of all five human breast carcinoma cell lines. Studies in three cell lines indicated low affinity (Kd, 1.6-3.0 X 10(-6) M) GnRH binding similar to that reported in human placenta and corpus luteum. In contrast, human pituitary GnRH receptors were of high affinity (Kd, 4.8 X 10(-9) M). Breast carcinoma cell GnRH-binding sites also differed from the pituitary receptor in their inability to discriminate between GnRH and superactive analogs. Binding of a [125I]GnRH analog to ZR-75-1 breast cancer cells and pituitary membranes was affected similarly by various cations. GnRH antagonists rapidly inhibited [3H]thymidine incorporation into DNA (within 3 hr), and this effect was reversible. GnRH antagonists also inhibited cell growth, but only after 6 days. GnRH agonists did not alter either thymidine incorporation or growth. The present observations of low affinity GnRH-binding sites in breast cancer cell lines and inhibitory effects of GnRH antagonists point to the possibility of an autocrine regulatory role of GnRH-like peptides in mammary cells.

This article has been cited by other articles:

				A. R Finch, K. R Sedgley, C. J Caunt, and C. A McArdle Plasma membrane expression of GnRH receptors: regulation by antagonists in breast, prostate, and gonadotrope cell lines J. Endocrinol., February 1, 2008; 196(2): 353 - 367. [Abstract] [Full Text] [PDF]

				K. R Sedgley, A. R Finch, C. J Caunt, and C. A McArdle Intracellular gonadotropin-releasing hormone receptors in breast cancer and gonadotrope lineage cells J. Endocrinol., December 1, 2006; 191(3): 625 - 636. [Abstract] [Full Text] [PDF]

				A. R Gunthert, C. Grundker, A. Olota, J. Lasche, N. Eicke, and G. Emons Analogs of GnRH-I and GnRH-II inhibit epidermal growth factor-induced signal transduction and resensitize resistant human breast cancer cells to 4OH-tamoxifen Eur. J. Endocrinol., October 1, 2005; 153(4): 613 - 625. [Abstract] [Full Text] [PDF]

				R. P. Millar and A. J. Pawson Outside-In and Inside-Out Signaling: The New Concept that Selectivity of Ligand Binding at the Gonadotropin-Releasing Hormone Receptor Is Modulated by the Intracellular Environment Endocrinology, August 1, 2004; 145(8): 3590 - 3593. [Full Text] [PDF]

				A. R. Finch, L. Green, J. N. Hislop, E. Kelly, and C. A. McArdle Signaling and Antiproliferative Effects of Type I and II Gonadotropin-Releasing Hormone Receptors in Breast Cancer Cells J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1823 - 1832. [Abstract] [Full Text] [PDF]

				G. Bifulco, C. Miele, M. Pellicano, A. Trencia, M. Ferraioli, F. Paturzo, G.A. Tommaselli, F. Beguinot, and C. Nappi Molecular mechanisms involved in GnRH analogue-related apoptosis for uterine leiomyomas Mol. Hum. Reprod., January 1, 2004; 10(1): 43 - 48. [Abstract] [Full Text] [PDF]

				L. E. C. Miles, A. C. Hanyaloglu, J. R. Dromey, K. D. G. Pfleger, and K. A. Eidne Gonadotropin-Releasing Hormone Receptor-Mediated Growth Suppression of Immortalized L{beta}T2 Gonadotrope and Stable HEK293 Cell Lines Endocrinology, January 1, 2004; 145(1): 194 - 204. [Abstract] [Full Text] [PDF]

				W.-H. Yang, M. Wieczorck, M. C. Allen, and T. M. Nett Cytotoxic Activity of Gonadotropin-Releasing Hormone (GnRH)-Pokeweed Antiviral Protein Conjugates in Cell Lines Expressing GnRH Receptors Endocrinology, April 1, 2003; 144(4): 1456 - 1463. [Abstract] [Full Text] [PDF]

				A. Ben-Yehudah, R. Aqeilan, D. Robashkevich, and H. Lorberboum-Galski Using Apoptosis for Targeted Cancer Therapy by a New Gonadotropin Releasing Hormone-DNA Fragmentation Factor 40 Chimeric Protein Clin. Cancer Res., March 1, 2003; 9(3): 1179 - 1190. [Abstract] [Full Text] [PDF]

				A. Chen, E. Kaganovsky, S. Rahimipour, N. Ben-Aroya, E. Okon, and Y. Koch Two Forms of Gonadotropin-releasing Hormone (GnRH) Are Expressed in Human Breast Tissue and Overexpressed in Breast Cancer: A Putative Mechanism for the Antiproliferative Effect of GnRH by Down-Regulation of Acidic Ribosomal Phosphoproteins P1 and P2 Cancer Res., February 1, 2002; 62(4): 1036 - 1044. [Abstract] [Full Text] [PDF]

				C. Gründker, K. Schulz, A. R. Günthert, and G. Emons Luteinizing Hormone-Releasing Hormone Induces Nuclear Factor {kappa}B-Activation and Inhibits Apoptosis in Ovarian Cancer Cells J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3815 - 3820. [Abstract] [Full Text]

				I. Chatzistamou, A. V. Schally, A. Nagy, P. Armatis, K. Szepeshazi, and G. Halmos Effective Treatment of Metastatic MDA-MB-435 Human Estrogen-independent Breast Carcinomas with a Targeted Cytotoxic Analogue of Luteinizing Hormone-releasing Hormone AN-207 Clin. Cancer Res., October 1, 2000; 6(10): 4158 - 4165. [Abstract] [Full Text]

				P. Bull, P. Morales, C. Huyser, T. Socias, and E.A. Castellon Expression of GnRH receptor in mouse and rat testicular germ cells Mol. Hum. Reprod., July 1, 2000; 6(7): 582 - 586. [Abstract] [Full Text] [PDF]

				P. Limonta, R. M. Moretti, M. M. Marelli, D. Dondi, M. Parenti, and M. Motta The Luteinizing Hormone-Releasing Hormone Receptor in Human Prostate Cancer Cells: Messenger Ribonucleic Acid Expression, Molecular Size, and Signal Transduction Pathway Endocrinology, November 1, 1999; 140(11): 5250 - 5256. [Abstract] [Full Text]

				A. Kimura, M. Ohmichi, H. Kurachi, H. Ikegami, J. Hayakawa, K. Tasaka, Y. Kanda, Y. Nishio, H. Jikihara, N. Matsuura, et al. Role of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Cascade in Gonadotropin-releasing Hormone-induced Growth Inhibition of a Human Ovarian Cancer Cell Line Cancer Res., October 1, 1999; 59(20): 5133 - 5142. [Abstract] [Full Text] [PDF]

				F. Raga, E. M. Casañ, J. S. Kruessel, Y. Wen, H.-Y. Huang, C. Nezhat, and M. L. Polan Quantitative Gonadotropin-Releasing Hormone Gene Expression and Immunohistochemical Localization in Human Endometrium Throughout the Menstrual Cycle Biol Reprod, July 1, 1998; 59(3): 661 - 669. [Abstract] [Full Text]

				A. Nechushtan, S. Yarkoni, I. Marianovsky, and H. Lorberboum-Galski Adenocarcinoma Cells Are Targeted by the New GnRH-PE66 Chimeric Toxin through Specific Gonadotropin-releasing Hormone Binding Sites J. Biol. Chem., April 25, 1997; 272(17): 11597 - 11603. [Abstract] [Full Text] [PDF]